Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · IEX Real-Time Price · USD
46.14
+0.10 (0.22%)
At close: Jul 19, 2024, 4:00 PM
46.19
+0.05 (0.11%)
Pre-market: Jul 22, 2024, 7:15 AM EDT
Revolution Medicines Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for RVMD stock have an average target of 47.46, with a low estimate of 30 and a high estimate of 62. The average target predicts an increase of 2.86% from the current stock price of 46.14.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RVMD stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 6 | 6 | 6 | 6 |
| Buy | 5 | 6 | 5 | 6 | 6 | 7 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 11 | 12 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $52 → $54 | Buy | Maintains | $52 → $54 | +17.04% | Jul 18, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $45 → $55 | Buy | Maintains | $45 → $55 | +19.20% | Jul 16, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $48 → $55 | Strong Buy | Maintains | $48 → $55 | +19.20% | Jul 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $44 → $56 | Strong Buy | Maintains | $44 → $56 | +21.37% | Jul 16, 2024 |
| Needham | Needham | Strong Buy Maintains $46 → $62 | Strong Buy | Maintains | $46 → $62 | +34.37% | Jul 16, 2024 |
Financial Forecast
Revenue This Year
6.31M
from 11.58M
Decreased by -45.49%
Revenue Next Year
7.85M
from 6.31M
Increased by 24.33%
EPS This Year
-3.18
from -3.86
EPS Next Year
-3.57
from -3.18
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 38.0M | 46.2M | 114.8M | 564.7M | 1.0B |
| Avg | 6.3M | 7.8M | 27.8M | 212.0M | 602.2M |
| Low | n/a | n/a | n/a | n/a | 215.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 228.3% | 632.1% | 1,362.4% | 1,930.1% | 381.1% |
| Avg | -45.5% | 24.3% | 254.4% | 662.2% | 184.0% |
| Low | - | - | - | - | 1.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.15 | -3.16 | -2.36 | 0.45 | 3.17 |
| Avg | -3.18 | -3.57 | -3.61 | -1.82 | -0.05 |
| Low | -3.55 | -3.88 | -4.41 | -3.97 | -2.21 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.